Medicare's Coverage of GLP-1 Drugs for Weight Loss
Medicare Part D (prescription drug coverage) does not cover GLP-1 medications when prescribed solely for weight loss. These drugs — including semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) — are covered only when used to treat type 2 diabetes. If your doctor prescribes a GLP-1 drug for weight management alone, you will pay the full cost out of pocket.
This distinction matters because the same medication can have two different coverage rules depending on the diagnosis code your doctor uses. A GLP-1 prescribed for diabetes is a covered benefit under Part D. The identical drug prescribed for weight loss is not. Your pharmacy will know which applies based on what your doctor writes on the prescription.
Medicare Part B (hospital and medical services) does not cover weight loss drugs under any circumstance. Bariatric surgery may be covered in limited cases, but medications for weight management fall outside Part B's scope.
Key Takeaways
- GLP-1 medications are covered by Medicare Part D only when prescribed to treat type 2 diabetes, not when prescribed for weight loss alone.
- The same drug (for example, semaglutide) has different coverage depending on whether your doctor codes it as diabetes treatment or weight loss treatment.
- If a GLP-1 is covered under your Part D plan, you still pay your plan's copay or coinsurance, which varies by plan and by whether the drug is on your plan's formulary.
- Many Part D plans place GLP-1 drugs in a high cost-sharing tier, meaning your out-of-pocket cost may be substantial even when the drug is covered.
- If you cannot afford a GLP-1 drug through Medicare, manufacturer discount programs and patient information programs may lower your cost.
How Part D Formularies Affect Your Cost
Each Medicare Part D plan maintains a formulary — a list of covered drugs. GLP-1 medications appear on most formularies, but not all, and placement on the formulary determines your cost. Plans typically sort drugs into tiers: tier 1 (lowest cost), tier 2, tier 3, and specialty tiers (highest cost).
Most plans place GLP-1 drugs in tier 3 or the specialty tier, meaning you pay a higher percentage of the cost or a higher fixed copay. A tier 3 copay might be $75 to $150 per month; a specialty tier copay can reach $250 or more. Some plans require prior authorization — your doctor must request permission from the plan before the pharmacy will fill the prescription — or step therapy, meaning you must try and fail a cheaper diabetes drug first.
Your Part D plan's formulary can change each year. If a GLP-1 drug was covered last year, it may move to a different tier or be removed entirely in the new plan year. Review your plan's formulary in October during the annual enrollment period to see what your costs will be.
When GLP-1 Is Covered Under Part D
Your doctor must diagnose you with type 2 diabetes and write the prescription with that diagnosis code for Medicare to cover the drug. The diagnosis code (a number like E11.9 for type 2 diabetes) is what triggers coverage, not the medication name itself. Your pharmacy submits this code to Medicare when processing the claim.
If your doctor prescribes a GLP-1 for prediabetes, metabolic syndrome, or weight loss without a diabetes diagnosis, Medicare will not cover it. Some doctors may code the prescription as diabetes treatment even if your blood sugar is borderline, but this practice is considered off-label coding and carries legal and billing risk. The safest approach is to have an honest conversation with your doctor about what diagnosis they will use and what your actual coverage will be.
Once the prescription is filled, you pay your plan's cost-sharing amount — copay, coinsurance, or both — just as you would for any other covered drug. You do not pay the full retail price, but you do pay something.
Out-of-Pocket Costs and the Donut Hole
Even when a GLP-1 is covered, your total out-of-pocket spending counts toward your Part D deductible and your plan's annual out-of-pocket maximum. Once you reach your plan's deductible (typically $505 to $550 in 2024, though this varies by plan), your cost-sharing begins. As you spend more, you may enter the coverage gap, sometimes called the "donut hole."
In the donut hole, you pay a larger share of the drug's cost — currently 25 percent of the cost for most drugs, though this percentage changes yearly. For an expensive drug like a GLP-1, the donut hole can mean hundreds of dollars in additional out-of-pocket cost per month. Once your total out-of-pocket spending reaches your plan's catastrophic threshold (around $7,050 in 2024), Medicare covers 95 percent of the cost and you pay only 5 percent.
If you use a GLP-1 drug regularly, you may hit the donut hole and catastrophic coverage within a few months. Understanding where you are in your plan's cost structure helps you budget and plan refills.
Manufacturer Discounts and Patient information Programs
If your Part D cost-sharing is high, the drug manufacturer may offer a discount program. Novo Nordisk (which makes semaglutide) and Eli Lilly (which makes tirzepatide) both run programs that reduce out-of-pocket costs for people with Medicare. These programs typically cap your monthly copay at $0 to $99, depending on your income and plan.
To use a manufacturer discount, you enroll directly with the company, usually through their website or by calling their patient support line. You receive a discount card that you present at the pharmacy along with your Medicare card. The discount applies to your copay only — it does not change what Medicare or your Part D plan pays.
Some nonprofit organizations also offer copay information for people taking GLP-1 drugs. The Patient Advocate Foundation and NeedyMeds maintain searchable databases of these programs. may be able to access usually depends on your income and whether you have insurance.
Alternatives If GLP-1 Is Not Covered or Affordable
If your Part D plan does not cover GLP-1 drugs or your cost-sharing is unaffordable, you have several options. First, ask your doctor whether switching to a different Part D plan during the annual enrollment period would lower your cost. Some plans cover GLP-1 drugs in a lower tier or with a lower copay than others.
Second, ask your doctor about older diabetes medications that may be covered at a lower cost tier. Metformin, sulfonylureas, and SGLT2 inhibitors are often covered with minimal copays. These drugs do not work the same way as GLP-1s, but they do treat type 2 diabetes and may help with weight loss in some people.
Third, if you do not have a diabetes diagnosis, talk with your doctor about whether you meet the criteria for one. Prediabetes (fasting blood sugar between 100 and 125) does not trigger coverage, but type 2 diabetes does. If your blood sugar is in the diabetic range, treating it with a GLP-1 is medically appropriate and covered.
Fourth, some people purchase GLP-1 drugs through telehealth companies or compounding pharmacies at a lower cash price than the retail pharmacy price. These options fall outside Medicare and require you to pay the full cost, but the price may be lower than your copay plus coinsurance combined. Compare prices carefully and verify that the pharmacy is licensed and legitimate.
Medicare Advantage Plans and GLP-1 Coverage
If you have a Medicare Advantage plan (Part C) instead of Original Medicare with Part D, your coverage for GLP-1 drugs depends on your specific plan. Medicare Advantage plans are required to cover at least as much as Original Medicare, so they must cover GLP-1 drugs when prescribed for diabetes. However, your copay, coinsurance, and prior authorization requirements may differ from Part D.
Some Medicare Advantage plans cover GLP-1 drugs in a lower cost-sharing tier than Part D plans do, while others place them in a higher tier. You can compare GLP-1 coverage across Medicare Advantage plans in your area during the annual enrollment period. Contact each plan directly or review their formularies on Medicare.gov to see what your cost would be.
If you are considering switching from Original Medicare to a Medicare Advantage plan partly because of GLP-1 coverage, ask the plan in writing whether the drug is covered, what your copay will be, and whether prior authorization is required. Get the answer in writing so you have proof if there is a dispute later.
Frequently Asked Questions
Can I get Medicare to cover GLP-1 for weight loss if I have prediabetes?
No. Medicare covers GLP-1 drugs only for type 2 diabetes, not prediabetes. Prediabetes is a precursor condition but does not meet the coverage threshold. If your blood sugar progresses to the diabetic range, you would then be covered.
What if my doctor prescribes a GLP-1 for diabetes but I am really taking it for weight loss?
The coverage rule depends on the diagnosis code your doctor submits, not on your reason for taking the drug. If your doctor codes it as diabetes treatment and you have a diabetes diagnosis, it is covered. However, using a diagnosis code that does not match your actual condition is considered insurance fraud and carries legal risk. Have an honest conversation with your doctor about your goals and what diagnosis applies to you.
Will my Part D plan cover the same GLP-1 drug next year?
Maybe not. Formularies change every year, and a drug that is covered this year may move to a higher cost tier or be removed next year. Review your plan's formulary each October during the annual enrollment period. If your current plan raises the cost of your GLP-1 drug, you can switch to a different Part D plan that offers better coverage.
How much does a GLP-1 drug cost without insurance?
Retail prices vary by drug and pharmacy, but GLP-1 medications typically cost $900 to $1,500 per month without insurance. This is why manufacturer discounts and patient information programs are important — they can reduce your cost to a fixed copay even if you have high cost-sharing under your plan.
Can I use a GLP-1 drug from a telehealth company instead of getting it through Medicare?
Yes. Some telehealth companies and compounding pharmacies sell GLP-1 drugs directly to consumers without involving insurance. You pay the full cost out of pocket, but the price may be lower than your Medicare copay plus coinsurance. Verify that the company is licensed, that the drug is manufactured by an FDA-approved maker, and that you have a real doctor-patient relationship before ordering.